title: Adverse events raise concerns over safety of new hepatitis C drugs.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology; D016174:Hepacivirus / Q000187:drug effects*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D017114:Liver Failure, Acute / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load / Q000187:drug effects
chemical_list: D000998:Antiviral Agents